Skip to main content

Day: October 1, 2025

RCP Advisors Closes Secondary Opportunity Fund V on $1.26 Billion, Exceeding Target Size

DALLAS, Oct. 01, 2025 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX), a leading private markets solutions provider, and RCP Advisors, a private equity firm specializing in North American small buyout strategies, are pleased to announce the final close of RCP Secondary Opportunity Fund V, LP (“RCP SOF V” or the “Fund”). The Fund was oversubscribed, closing on $1.26 billion in capital commitments, exceeding its initial target of $1 billion.1 The Fund has a broad base of limited partners, comprised of both new and existing investors, including high net worth individuals, pension funds, endowments, foundations, and insurance companies. “We congratulate RCP Advisors on the successful close of RCP SOF V, which we believe exemplifies both investor confidence in the firm’s strategy and the growing demand for North American small buyout funds,”...

Continue reading

Roche commences tender offer for all shares of 89bio, Inc. for $14.50 per share in cash, plus a non-tradeable contingent value right for up to $6.00 per share in cash

Basel, 1 October 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has commenced a tender offer for all of the outstanding shares of common stock of 89bio, Inc. (89bio) (NASDAQ: ETNB) at a price of $14.50 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain milestone payments of up to an aggregate of $6.00 per share in cash. The tender offer is being made pursuant to the previously announced merger agreement dated as of September 17, 2025, among Roche Holdings, Inc., an indirect wholly owned subsidiary of Roche Holding Ltd, Bluefin Merger Subsidiary, Inc., a wholly owned subsidiary of Roche Holdings, Inc., and 89bio. The tender offer period will expire at one minute after 11:59 p.m., New York City time on October 29, 2025, unless the offer is extended. Roche has filed a tender offer...

Continue reading

Twin Disc to Present at Noble Virtual Equity Conference

MILWAUKEE, Oct. 01, 2025 (GLOBE NEWSWIRE) — Twin Disc, Inc. (NASDAQ: TWIN) today announced that Chief Executive Officer John Batten and Chief Financial Officer Jeff Knutson are presenting at the Noble Emerging Growth Virtual Equity Conference on Wednesday, October 8 at 3:30 pm Central. In conjunction with the event, Twin Disc executives will be available to participate in one-on-one meetings with investors registered to attend the conference. A recording of the event will be available on the Investor Presentations section of Twin Disc’s website at https://ir.twindisc.com. About Twin Disc Twin Disc, Inc. designs, manufactures and sells marine and heavy-duty off-highway power transmission equipment. Products offered include marine transmissions, azimuth drives, surface drives, propellers and boat management systems, as well as power-shift...

Continue reading

TOMI Environmental Solutions Appoints Harold W. Paul to Its Board of Directors

– Brings Over 40 years of Legal, Securities, and Board Leadership Experience Across Multiple Industries – FREDERICK, Md., Oct. 01, 2025 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist brand of products, today announced the appointment of Mr. Harold W. Paul to its Board of Directors, effective immediately. He succeeds Ms. Kelly J. Anderson, who has resigned from the Board effective as of September 30, 2025. Mr. Paul brings more than 40 years of legal and securities expertise, along with extensive board leadership experience across technology, financial services, and other industries. He previously served as a member of TOMI’s Board from...

Continue reading

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine

Maetzold recognized among 586 applicants to The CEO Magazine’s 2025 Executive of the Year Awards — United States programFRIENDSWOOD, Texas, Oct. 01, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its founder, president and chief executive officer Derek Maetzold has been awarded the CEO of the Year by The CEO Magazine. The Executive of the Year Awards program recognizes senior executives driving measurable impact, innovation and inspiration. “This honor affirms what we at Castle have long known: Derek is a visionary leader whose ability to pair scientific innovation with a people-first approach has made a marked impact on patient care and our company,” said Frank Stokes, chief financial officer of Castle Biosciences....

Continue reading

UMH PROPERTIES, INC. THIRD QUARTER 2025 OPERATIONS UPDATE

FREEHOLD, NJ, Oct. 01, 2025 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE: UMH; TASE: UMH), a real estate investment trust (REIT) specializing in the ownership and operation of manufactured home communities, is providing investors with an update on the third quarter of 2025 operating results:We converted 223 new homes from inventory to revenue generating rental homes. Year-to-date, we have converted 528 new homes from inventory to revenue generating rental homes. UMH now owns approximately 10,800 rental homes with an occupancy rate of 94.1%.Same Property occupancy increased by 132 units during the third quarter and 357 units over the same period last year to 88.5%.We achieved gross home sales revenue of $9.2 million compared to $8.7 million last year, representing an increase of approximately 5%. Additionally, we achieved...

Continue reading

Skeena Resources Limited Announces Approximately C$125 Million Bought Deal Financing

VANCOUVER, British Columbia, Oct. 01, 2025 (GLOBE NEWSWIRE) — Skeena Resources Limited (TSX: SKE; NYSE: SKE) (“Skeena Gold & Silver”, “Skeena” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 5,210,000 common shares of the Company (the “Common Shares”), at a price of C$24.00 per Common Share for aggregate gross proceeds of approximately C$125 million (the “Offering”). The Company has granted the Underwriters an option, exercisable at the offering price for a period of 30 days following the closing of the Offering, to purchase up to an additional 15% of the Offering to cover over-allotments, if any (the “Over-Allotment Option”). The proceeds...

Continue reading

Innospec Schedules Third Quarter 2025 Earnings Release and Conference Call

ENGLEWOOD, Colo., Oct. 01, 2025 (GLOBE NEWSWIRE) — Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2025 earnings on Tuesday, November 4, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 5, 2025, at 10:00 a.m. ET. The public is invited to listen to the conference call by registering in advance using the below Online Registration Link.   Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique Personal PIN which can be used to join the conference 5-10 minutes prior to the start time. Online Registration Link: https://register-conf.media-server.com/register/BIa2f28ba8cf3642be92efbae1ec3e14f9 An...

Continue reading

Guggenheim Investments Announces October 2025 Closed-End Fund Distributions

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) — Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”). The following dates apply to the distributions:Record Date October 15, 2025Ex-Dividend Date October 15, 2025Payable Date October 31, 2025Distribution ScheduleNYSE Ticker Closed-End Fund Name Distribution Per Share Change from Previous Distribution FrequencyAVK Advent Convertible and Income Fund $0.1172†   MonthlyGBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust $0.12573†   MonthlyGOF Guggenheim Strategic Opportunities Fund $0.1821†   MonthlyGUG Guggenheim Active Allocation Fund $0.11875†   Monthly         †...

Continue reading

Fidus Investment Corporation Prices Public Offering of $100 Million of 6.750% Notes Due 2030

EVANSTON, Ill., Oct. 01, 2025 (GLOBE NEWSWIRE) — Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”) today announced that it has priced an underwritten public offering of an additional $100 million aggregate principal amount of 6.750% notes due 2030 (the “Notes”). The Notes will constitute a further issuance of, have the same terms (except the issue date, the offering price and the initial interest payment date) as, rank equally in right of payment with, and be fungible and form a single series with the $100 million in aggregate principal amount of the 6.750% notes due 2030 that the Company initially issued on March 19, 2025. Upon the issuance of the Notes, the outstanding aggregate principal amount of the Company’s 6.750% notes due 2030 will be $200 million. The Notes will mature on March 19, 2030, and may be...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.